Pharma 2100
Technology
Pharma2100 has developed a wound care product that includes active pharmaceutical ingredients. The product provides moist wound healing, similar to wound-care dressings, and it act as a vehicle for trans-dermal delivery of the active ingredient. A "slow release" system ensures a constant presence of the active substance, further reducing the time required to heal the wound.
Value Proposition
Non-healing ulcers are a major concern in the primary care sector and a significant cause of morbidity. Pharma2100 provides a cost-efficient and effective treatment of these types of wounds.
Additional Information